US Earnings Financial Results SEC Filings — June 24, 2026

24-06-2026

Cerebras Systems reported Q1 2026 revenue of $193.4M, up 94.4% YoY from $99.5M, with gross profit more than doubling to $86.2M (44.6% margin vs 41.8% a year ago). Net loss narrowed 41.3% to $14.0M from $23.9M, and operating cash flow turned positive at $12.3M versus negative $54.9M in Q1 2025. However, cash burn from investing remained heavy at $236.6M, and the company's accumulated deficit widened to $919.3M from $905.3M at year-end 2025.

• · Cash and cash equivalents surged 144.6% from $701.7M at Dec 31, 2025 to $1.7B at Mar 31, 2026, driven primarily by $1.0B from Series H preferred stock issuance and $1.0B from a Working Capital Loan.
• · Total assets more than doubled to $4.9B, while total liabilities grew to $2.2B from $971.3M, largely due to the addition of $982.9M in working capital loan (current + non-current).
• · Redeemable convertible preferred stock increased by $1.0B, with 11.4 million shares of Series H issued during the quarter.
• · Stock-based compensation expense was $9.4M in Q1 2026, modestly up from $9.2M in Q1 2025.
• · Property and equipment purchases totaled $132.0M, up 34.3% from $98.2M in prior year quarter.
• · Customer warrants recognized as a non-cash item contributed $365.8M to additional paid-in capital.
• · The company maintained no long-term debt other than the working capital loan; no defaults were reported.

24-06-2026

C3.ai reported total revenue of $250.3M for fiscal year 2026, a 36% decline from $389.1M in FY2025, driven by a 31% drop in subscription revenue and a 62% plunge in professional services. Gross profit fell 67% to $77.4M, and net loss widened to $470.4M from $288.7M, as operating expenses rose 3% and included $10.8M in restructuring charges. While subscription revenue still comprised 91% of total revenue, gross margin collapsed to 31% from 61% due to a sharp rise in subscription cost of revenue.

• · Subscription revenue as a percentage of total revenue increased to 91% in FY2026 from 84% in FY2025, despite the absolute decline.
• · Stock-based compensation expense rose to $268.5M in FY2026 from $231.0M in FY2025, a 16% increase.
• · Interest income declined 21% to $28.4M in FY2026 from $36.2M in FY2025.
• · Sales and marketing expense remained nearly flat at $237.4M (down 1% YoY), while R&D expense increased slightly by 1% to $229.1M.
• · General and administrative expense grew 5% to $98.6M in FY2026.
• · Restructuring charges of $10.8M were incurred in FY2026, with no comparable charge in FY2025.

24-06-2026

Crown Crafts Inc. reported net income of $1.843M for fiscal year 2026, a significant improvement from a net loss of $9.356M in fiscal 2025, driven by the absence of a $13.766M goodwill impairment charge and higher other income. However, total net sales declined 5.7% to $82.266M, with bedding and diaper bags falling 14.8%, while bibs, toys and disposable products grew modestly by 2.4%. Gross margin remained flat at 24.4%, and marketing expenses increased as a percentage of sales, indicating ongoing cost pressures.

• · The company's gross margin remained flat at 24.4% of net sales in both fiscal years.
• · Marketing and administrative expenses increased to 23.1% of net sales in fiscal 2026 from 21.4% in fiscal 2025.
• · Cash and cash equivalents decreased sharply by 61.6% to $200K as of March 29, 2026, from $521K a year earlier.
• · Total assets declined 12.9% to $70.653M, primarily due to reductions in accounts receivable and operating lease right-of-use assets.
• · Long-term debt was reduced by 26.5% to $12.132M from $16.512M.
• · Shareholders' equity decreased slightly by 2.0% to $38.813M, as net income was offset by dividends and treasury stock acquisitions.
• · The company declared dividends of $0.32 per share in both fiscal years.
• · The allowance for expected credit losses increased to $410K at March 29, 2026 from $274K at March 30, 2025.
• · The company has seven leased properties across the U.S. and China, with the largest being the Compton, California facility at 157,400 sq ft.
• · KPMG LLP served as the independent registered public accounting firm (Auditor Firm ID: 185).

24-06-2026

Crypto Co (CRCW) filed its 10-K for the year ended December 31, 2025, reporting a net loss of $1.98 million, a significant improvement from the $7.96 million loss in 2024. The company held $123,794 in cryptocurrency and $97,205 in cash at year-end, versus only $1,763 in cash a year earlier. However, revenue from services fell sharply to $18,527 from $44,814, and the company remains deeply in deficit with total stockholders' deficit of $6.1 million.

• · The company held $123,794 in cryptocurrency at December 31, 2025, compared to zero a year earlier.
• · Total liabilities decreased to $6,319,522 from $8,019,522, a 21.2% reduction.
• · Accumulated deficit widened to $56,706,954 from $54,725,828.
• · Weighted average common shares outstanding increased to 3,729,589,754 from 1,943,159,789.
• · Net cash used in operating activities increased to $1,411,627 from $813,546.
• · The company had a gain on forgiveness of debt of $1,545,211 and a gain on extinguishment of debt of $233,991 in 2025.
• · Realized loss on sale of cryptocurrency was $258,413 in 2025.
• · Interest expense more than doubled to $1,135,607 from $503,003.
• · Common stock issued to reduce convertible debt was $1,702,020 in 2025, down from $2,823,314 in 2024.
• · Common stock issued to reduce accrued liabilities was $711,000 in 2025 (none in 2024).
• · Stock options outstanding remained unchanged at 2,281,429 with a weighted average exercise price of $2.26.

24-06-2026

Methode Electronics reported a net loss of $35.7M for fiscal year 2026, improving from a net loss of $62.6M in fiscal 2025, driven by a significant gross margin recovery from 15.6% to 19.8%. However, total net sales declined 2.8% to $1,019.2M, with North America sales falling 20.7% to $188.1M, while the EMEA segment grew 2.9% to $246.5M and Asia was flat at $33.1M. The company generated $38.0M in operating cash flow, up from $26.4M, and ended the period with $139.6M in cash.

• · North America segment net sales declined 20.7% YoY to $188.1M, while gross profit margin improved from 0.9% to 5.9%.
• · EMEA segment net sales grew 2.9% YoY to $246.5M, with gross profit margin improving from 29.6% to 31.9%.
• · Asia segment net sales were flat at $33.1M, with gross profit margin declining slightly from 24.5% to 23.9%.
• · Total assets remained essentially flat at $1,306.1M vs $1,305.8M.
• · Shareholders' equity decreased 2.3% to $677.5M from $693.3M.
• · Long-term debt increased 2.3% to $324.8M from $317.4M.
• · The Grakon Industrial reporting unit had $125.1M of goodwill as of May 2, 2026, and the company determined its fair value exceeded carrying value.
• · Cash and cash equivalents increased 34.7% to $139.6M from $103.6M.
• · Net cash provided by operating activities improved to $38.0M from $26.4M.
• · Net cash used in financing activities decreased to $14.2M from $58.9M.
• · Net cash provided by investing activities was $1.3M vs a use of $32.9M in the prior year.
• · The company had 36,806,583 shares issued as of May 2, 2026, down from 37,151,365 shares a year earlier.
• · Accumulated other comprehensive loss improved from -$29.8M to -$8.8M.
• · Retained earnings decreased to $479.3M from $524.2M.

24-06-2026

Daktronics reported a strong turnaround for fiscal year 2026, with net income of $45.4M versus a net loss of $(10.1M) in 2025. Revenue grew 10.9% to $838.7M, driven by growth in all segments except Transportation (-5.4%). However, cash flow from operations dropped significantly to $49.2M from $97.7M, and the Transportation segment saw a 25.2% decline in operating income.

• · Diluted earnings per share improved to $0.92 in FY2026 from $(0.21) in FY2025.
• · General and administrative expenses decreased 5.7% YoY to $59.9M.
• · Product design and development expenses increased 11.8% to $43.5M.
• · The company has 5 owned facilities and 3 leased facilities, with total owned square footage of 984,000 and leased square footage of 551,000.
• · Total assets increased to $554.4M from $502.9M.
• · Long-term debt, net decreased slightly to $9.6M from $10.5M.
• · Stockholders' equity rose to $300.7M from $271.9M (calculated from retained earnings etc.) but treasury stock increased to $(65.3M) from $(39.8M).
• · Commercial segment contribution margin surged 56.7%, and International segment turned from a negative contribution margin of $(3.5M) in FY2025 to a positive $5.7M in FY2026.

24-06-2026

21Shares Hyperliquid ETF filed its first 10-Q for the period ended March 31, 2026, disclosing no assets, liabilities, or net assets as of that date. The trust redeemed its initial seed shares and had zero shares outstanding, with no creation baskets redeemed by authorized participants. As of June 22, 2026, the entity reported 2,000,000 common shares outstanding, indicating that share issuance occurred shortly after the quarter end.

• · The trust redeemed two initial seed shares held by the Sponsor during the period from March 18, 2026 through March 31, 2026.
• · No creation baskets were redeemed by authorized participants during the period.
• · The trust had no shares outstanding as of March 31, 2026.
• · Entity is a non-accelerated filer, small business, and emerging growth company incorporated in Delaware.
• · Ticker symbol: THYP, listed on NASDAQ.

24-06-2026

CNBX Pharmaceuticals Inc. reported no revenue for the three and nine months ended May 31, 2026, with net losses widening to $154,165 (Q3) and $311,982 (nine months) compared to $59,727 and $163,867 in the prior-year periods. Cash and cash equivalents declined 37% from $15,111 at August 31, 2025 to $9,487 at May 31, 2026, while total assets fell 31% to $12,795. However, the company reduced its convertible loan by $150,053 to $1,047,204 and issued 921.8 million shares through conversion of debt, boosting common stock and additional paid-in capital.

• · The company had no revenue for any period reported.
• · Net loss per share was $0.00 for all periods due to high share count.
• · Short term loan of $120,000 was taken during the nine months ended May 31, 2026, with no such loan in the prior period.
• · Accounts payable and accrued liabilities decreased slightly from $49,252 to $45,228.
• · The company's accumulated deficit grew 1.2% to $25,580,358.
• · Weighted average shares outstanding surged from 42.6 million to 1.32 billion for the three-month period, a 2,996% increase.
• · Non-cash conversion of convertible loan to shares totaled $148,561 for the nine months ended May 31, 2026, up from $106,442 in the prior year.

24-06-2026

NOVAGOLD RESOURCES INC reported a net loss of $25.5M for Q2 2026 (three months ended May 31, 2026), compared to a net loss of $54.3M in the same quarter last year, an improvement driven by the absence of a $39.6M warrant expense in the prior year. However, operating losses widened to $25.8M from $12.3M, primarily due to a significant increase in equity losses from Donlin Gold ($16.9M vs $6.5M) and higher general & administrative expenses ($8.9M vs $5.8M). Cash and cash equivalents decreased sharply to $78.2M from $110.1M at November 30, 2025, as the company invested heavily in term deposits ($292M) and funded Donlin Gold ($31.9M) during the six-month period.

• · Total assets increased to $598.7M as of May 31, 2026 from $335.9M at November 30, 2025, primarily due to a $287M increase in term deposits.
• · Total liabilities increased to $177.7M from $172.1M, driven by a $7.4M increase in the promissory note.
• · Share-based compensation for the six months ended May 31, 2026 was $4.2M, up from $2.4M in the prior year period.
• · Net cash used in operating activities for the six months ended May 31, 2026 was $11.7M, compared to $7.1M in the prior year period.
• · The company issued 31.0 million common shares in a private placement during the six months ended May 31, 2026, raising $294.0M net of costs.
• · Donlin Gold funding for the six months ended May 31, 2026 was $31.9M, up from $10.4M in the prior year period.
• · The company's economic interest in Donlin Gold remained at 60%.
• · Net assets of Donlin Gold (NOVAGOLD's share) increased to $51.2M as of May 31, 2026 from $42.4M at November 30, 2025.

24-06-2026

CarMax reported net sales and operating revenues of $8.01B for the quarter ended May 31, 2026, up 6.2% from $7.55B in the prior-year period, driven by growth in used and wholesale vehicle sales. However, net earnings declined 11.8% to $185.6M from $210.4M, and gross profit margin contracted to 10.7% from 11.8%, reflecting higher cost of sales and increased interest expense.

• · Net cash provided by operating activities fell sharply to $17.6M from $299.5M in the prior-year quarter, a decline of 94.1%.
• · Inventory decreased to $4.06B from $4.14B at February 28, 2026, a reduction of 1.8%.
• · Total assets increased to $26.63B from $26.37B at February 28, 2026.
• · Shareholders' equity rose to $6.12B from $5.89B at February 28, 2026, driven by net earnings and other comprehensive income.
• · The company repurchased and retired $2.3M of common stock in Q1 FY26, compared to $204.0M in Q1 FY25, a significant reduction in buyback activity.
• · Provision for loan losses decreased to $95.6M from $101.7M, down 6.0% year-over-year.
• · Other comprehensive income was $20.2M in Q1 FY26 versus a loss of $11.3M in Q1 FY25, primarily due to cash flow hedge gains.

24-06-2026

For the fiscal year ended April 30, 2026, John Wiley & Sons reported GAAP revenue of $1,676.5M, nearly flat (-0.06%) compared to $1,677.6M in FY2025, while non-GAAP adjusted revenue rose 1.0% to $1,676.5M from $1,660.2M. GAAP operating income surged 25.1% to $276.9M from $221.4M, and non-GAAP adjusted operating income increased 18.2% to $296.2M from $250.5M. Net income more than doubled (163.3%) to $221.6M from $84.2M, driven largely by a $65.2M swing in tax benefit, but GAAP revenue was essentially flat and the non-GAAP adjusted effective tax rate rose to 24.4% from 21.0%.

• · Non-GAAP adjusted operating income rose 11% in the Research segment to $282.6M from $255.6M, with adjusted EBITDA margin improving to 33.2% from 32.1%.
• · Net loss on sale of businesses and impairment charges decreased sharply from $23.3M in FY2025 to $4.8M in FY2026.
• · GAAP effective tax rate swung from a provision of 41.1% in FY2025 to a benefit of 3.0% in FY2026 due to valuation allowance and other items; non-GAAP adjusted effective tax rate increased to 24.4% from 21.0%.
• · Restructuring and related charges declined to $19.2M from $25.6M.
• · Interest expense decreased 16.6% to $43.8M from $52.5M.